6 days Ago By Defense World Staff
Alliancebernstein L.P. reduced its holdings in shares of iRhythm Technologies, Inc.
(NASDAQ:IRTC – Free Report) by 96.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 39,717 shares of the company’s stock after selling 1,172,754 shares during the quarter.
Alliancebernstein L.P. owned 0.
13% of iRhythm Technologies worth $3,581,000 at the end of the most recent reporting period. Several other hedge funds and other institutional investors also recently made changes to their positions in the business. Wellington Management Group LLP boosted its stake in shares of iRhythm Technologies by 9.
3% in the 4th quarter. Wellington Management Group LLP now owns 233,840 shares of the company’s stock worth $21,085,000 after buying an additional 19,891 shares during the last quarter. Homestead Advisers Corp raised its stake in shares of iRhythm Technologies by 31.
9% in the fourth quarter. Homestead Advisers Corp now owns 28,100 shares of the company’s stock valued at $2,534,000 after buying an additional 6,800 shares during the period. EFG Asset Management North America Corp.
lifted its position in shares of iRhythm Technologies by 113.6% during the 4th quarter. EFG Asset Management North America Corp.
now owns 28,430 shares of the company’s stock valued at $2,565,000 after buying an additional 15,118 shares during the last quarter. Segall Bryant & Hamill LLC grew its stake in shares of iRhythm Technologies by 5.1% during the 4th quarter.
Segall Bryant & Hamill LLC now owns 139,391 shares of the company’s stock worth $12,569,000 after acquiring an additional 6,789 shares during the period. Finally, Vanguard Group Inc. increased its holdings in iRhythm Technologies by 0.
6% in the 4th quarter. Vanguard Group Inc. now owns 3,136,370 shares of the company’s stock worth $282,806,000 after acquiring an additional 18,442 shares during the last quarter.
iRhythm Technologies Stock PerformanceIRTC stock opened at $103.20 on Tuesday. The company has a market cap of $3.
24 billion, a P/E ratio of -28.35 and a beta of 1.45.
The company has a debt-to-equity ratio of 9.00, a current ratio of 6.27 and a quick ratio of 6.
12. iRhythm Technologies, Inc. has a 1 year low of $55.
92 and a 1 year high of $128.52. The stock’s fifty day moving average price is $106.
10 and its 200-day moving average price is $92.77. iRhythm Technologies (NASDAQ:IRTC – Get Free Report) last announced its earnings results on Thursday, February 20th.
The company reported $0.01 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.29) by $0.
30. iRhythm Technologies had a negative return on equity of 118.83% and a negative net margin of 19.
14%. The business had revenue of $164.33 million for the quarter, compared to analysts’ expectations of $158.
30 million. On average, equities analysts forecast that iRhythm Technologies, Inc. will post -1.
98 earnings per share for the current year. Analyst Upgrades and DowngradesA number of analysts recently issued reports on IRTC shares. Oppenheimer boosted their price objective on iRhythm Technologies from $105.
00 to $120.00 and gave the company an “outperform” rating in a research note on Wednesday, January 8th. Needham & Company LLC boosted their target price on iRhythm Technologies from $125.
00 to $138.00 and gave the stock a “buy” rating in a research report on Friday, February 21st. Wells Fargo & Company lifted their target price on shares of iRhythm Technologies from $86.
00 to $104.00 and gave the stock an “equal weight” rating in a research report on Friday, February 21st. Truist Financial raised their price target on iRhythm Technologies from $111.
00 to $145.00 and gave the stock a “buy” rating in a research report on Friday, February 21st. Finally, The Goldman Sachs Group boosted their target price on iRhythm Technologies from $91.
00 to $124.00 and gave the company a “neutral” rating in a research note on Monday, February 24th. Three equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock.
According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $119.73.
Check Out Our Latest Report on IRTCiRhythm Technologies Company Profile (Free Report)iRhythm Technologies, Inc, a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services.Further ReadingFive stocks we like better than iRhythm Technologies3 Healthcare Dividend Stocks to BuyWhy NVIDIA Stock Could Soar Despite Wall Street DowngradesValue Investing: Is it a Good Strategy in 2022? (Hint: Always)Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or HoldMost active stocks: Dollar volume vs share volume3 Hot New IPOs Defying the 2025 Market SlumpWant to see what other hedge funds are holding IRTC? Visit HoldingsChannel.
com to get the latest 13F filings and insider trades for iRhythm Technologies, Inc. (NASDAQ:IRTC – Free Report)..
